B in Mycobacterium tuberculosis-
induced Interleukin-2 Receptor Expression in
Mononuclear Phagocytes
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
ABSTRACT |
|---|
|
|
|---|
Soluble interleukin-2 receptor-
(IL-2R
) has been reported to be increased in the sera of patients
with advanced tuberculosis, and levels decline after therapy in accordance with improvement of radiologic findings. We investigated expression of the IL-2R
in bronchoalveolar lavage (BAL) cells in
active pulmonary tuberculosis, and evaluated the mechanism Mycobacterium tuberculosis induces in
the IL-2R
using the THP-1 mononuclear phagocyte cell line. We found IL-2R
expression to be increased in BAL cells from involved sites of active pulmonary tuberculosis. Expression of the
-chain of
IL-2R
on peripheral blood monocytes (PBM) was induced by M. tuberculosis by flow cytometry evaluation. Northern analysis demonstrated increased IL-2R
gene expression after stimulation with
M. tuberculosis which was further induced by interferon-
(IFN-
). The IL-2R
promoter containing
the nuclear factor kappa B (NF-
B) site was transcriptionally induced by M. tuberculosis and this NF-
B
site could confer inducibility to a heterologous herpes thymidine kinase (TK) promoter by M. tuberculosis. Electrophoretic mobility shift assays (EMSAs) revealed specific binding of nuclear protein to the
NF-
B site upon induction with M. tuberculosis. Using antibodies against the p50 and p65 subunits of
NF-
B in EMSAs, the involvement of both p50 and p65 proteins was further demonstrated. Functional expression of the IL-2R
on mononuclear phagocytes in M. tuberculosis infection may play an
important immunomodulatory role in the host response.
| |
INTRODUCTION |
|---|
|
|
|---|
Tuberculosis (TB) has been labeled a global emergency by the
World Health Organization because of the large number of infected persons and the reduced host defenses among those
with human immunodeficiency virus-1 (HIV-1) infection. Successful control of Mycobacterium tuberculosis in animal models has been characterized by CD4+ lymphocytes releasing
interleukin-2 (IL-2) and interferon-
(IFN-
) (1, 2). IL-2 activity in response to purified protein derivative (PPD) and expression of IL-2 receptors (IL-2R) on peripheral blood mononuclear cells (PBMC) of TB patients have been found to be reduced (3); in contrast, expression of IL-2 on adherent cells isolated from TB patients is markedly increased (4). In addition, soluble IL-2R are increased in the sera of patients with
TB, and levels decline after antituberculous therapy (5).
Blood monocytes from patients with TB express functional
IL-2R constitutively, and the functional expression of IL-2R
on monocytes has been proposed by Toossi and coworkers (4)
to limit the availability of IL-2 for T-cells, leading to depression of T-cell immune responses. In this context, the lack of a
delayed skin test reaction to the mycobacterial antigen tuberculin PPD has been observed in some patients with active tuberculosis (6, 7), and is associated with the failure of T cells to
proliferate in response to M. tuberculosis antigens (8). Peripheral blood monocytes (PBM) from patients with active pulmonary TB have also been shown to selectively depress lymphocyte responses to PPD (8, 9). Depletion of adherent monocytes
increased IL-2 activity of supernatants of PPD-stimulated
T-cell cultures. We have demonstrated that PBMC of TB patients had 10-fold fewer IL-2-responsive cells than that of control subjects (3). In addition to the immunomodulatory role of
monocyte IL-2R expression, interactions of IL-2 with its receptors may also play a role in microbicidal host defenses because intracellular killing of M. avium complex by monocytes
has been demonstrated to be enhanced in the presence of tumor necrosis factor-
(TNF-
) and IL-2 (10).
Activation of human PBM results in induction of expression of the gene encoding the
chain of interleukin-2 receptor
(IL-2R
) (11). IL-2R is composed of three distinct membrane components: the
,
, and
chains (16). IL-2R
and IL-2R
are constitutively expressed on freshly isolated human
monocytes and are sufficient to trigger activation of monocytes by IL-2 (17). The
chain is not constitutively expressed
in monocytes but can be induced by lipopolysaccharide (LPS)
or IFN-
but not by IL-2 (11, 21). LPS and IFN-
were additive in augmenting IL-2R
expression (12). Expression of IL-2R
is important for the formation of high-affinity binding
sites for IL-2 (16). Expression of IL-2R
may therefore function as an on-off switch that determines whether monocytes will respond to the low concentration of IL-2 found in vivo in the monocyte microenvironments. IL-2, originally described
as a T-cell growth factor, is a powerful activator of human
monocytes which respond to IL-2 with microbicidal and tumoricidal activities, cytokine production, and expression of
growth factor receptors (22, 23).
The transcription factor, nuclear factor kappa B (NF-
B) is
a protein complex that enables a variety of genes to be rapidly induced in response to extracellular stimuli (24). NF-
B is activated by antigens, viruses, bacteria, prooxidants, and inflammatory lymphokines and participates in the transcriptional
initiation of diverse genes important in immune and inflammatory responses such as IL-1, -2, -6, -8, IL-2R
, adhesion
molecules, major histocompatibility class I molecules, and immunoglobulin
light chain (25). NF-
B is formed by the noncovalent association of the p50 and p65 subunits which, upon
cellular activation, translocates to the nucleus and binds to the
NF-
B enhancer element. Transcriptional stimulation of the
IL-2R
gene can be induced upon T-cell activation and the role of NF-
B in the positive regulation of IL-2R
expression in T cells has been well established (26). Activation of NF-
B by IL-2 in human blood monocytes also results in functional activation of a heterologous promoter containing the
IL-2R
enhancer element (29). Because increased release of
soluble IL-2R
has been demonstrated in TB patients, we
studied the molecular mechanism of IL-2R
gene regulation
by M. tuberculosis.
| |
METHODS |
|---|
|
|
|---|
Study Population
Bronchoalveolar lavage (BAL) was performed on five patients with active pulmonary TB confirmed by culture of M. tuberculosis in the sputum or pleural fluid. The protocol was approved by Human Subjects Review Committees at New York University Medical Center and Bellevue Hospital. We also evaluated two normal volunteers with normal chest radiographs, pulmonary function tests, and physical examinations. Both were nonsmokers; their mean age was 36 and 38 yr respectively; both were HIV-negative, and the normal controls were PPD-negative. All TB patients were PPD-positive and HIV-negative. BAL was performed in involved and uninvolved lobes as previously described in two patients (30). Cytospins revealed > 80% macrophages in all lavages.
Cell Culture and Reagents
PBMCs from healthy PPD-negative volunteers were isolated by sedimentation over Lymphocyte Separation Medium (Organon Teknika, West Chester, PA). PBM were isolated by plastic adherence on plastic dish for 1 h at 37° C. After removing nonadherent cells, the adherent cells were washed twice with phosphate-buffered saline (PBS) and dislodged by gentle scraping and resuspended in RPMI 1640 supplemented with 10% heat-inactivated fetal calf serum (FCS) plus penicillin and streptomycin, and were > 95% monocytes by esterase staining. The human myelomonocytic leukemic cell line THP-1 was purchased from American Type Culture Collection (Rockville, MD) and cultured in RPMI 1640 medium supplemented with 10% FCS. Cells were stimulated with heat-killed M. tuberculosis H37Ra (Difco, Detroit, MI)
which had been tested to be endotoxin-free (< 5 pg/ml) by amebocyte lysate assay (E-Toxate kit; Sigma, St. Louis, MO) or live M. tuberculosis H37Rv. LPS 055 was purchased from Sigma and IFN-
was a gift
from Genentech, Inc. (South San Francisco, CA). Anti-p50 and anti-p65 antibodies were purchased from Santa Cruz (Santa Cruz, CA).
Measurement of Surface IL-2 Receptor Expression
2 × 106 PBM were incubated for 48 h in the presence or absence of inducing agents. Cells were washed with PBS, resuspended in RPMI
1640 with 1% fetal bovine serum (FBS), 15 mM HEPES (pH 7.9), and
0.1% sodium azide and incubated with fluorescein isothiocyanate (FITC)-conjugated CD25 antibody (anti-IL-2R
) (Becton Dickinson, San Jose, CA) on ice for 30 min. Cells were washed and analyzed by
FACScan (Becton Dickinson). Surface IL-2R
expression was quantitated and represented as mean fluorescence intensities (MFIs).
Northern Blot Analysis
PBM were stimulated with H37Ra in the presence or absence of IFN-
for 12 h. Cytoplasmic RNA from BAL cells from TB patients or normal control subjects was isolated by the guanidine thiocyanate-cesium chloride (CsCl2) centrifugation method. Equal amounts of RNA were fractionated by electrophoresis through 0.8% agarose/formaldehyde gel and transferred onto nylon membrane (Hybond N; Amersham, Arlington Heights, IL). The membrane was hybridized at 65° C in Church
buffer (7% sodium dodecylsulfate [SDS], 1% bovine serum albumin
[BSA], 1 mM ethylenediaminetetraacetic acid [EDTA], 0.25 M Na2HPO4) containing the IL-2R
or pHe7 complementary DNA (cDNA)
radiolabeled by random priming with radioactive phosphorus-deoxycytidine triphosphate ([
-32P]dCTP). The filter was washed in 2× saline sodium citrate (SSC)-0.5% SDS at room temperature for 5 min,
2 × SSC-0.1% SDS at room temperature for 15 min, and 0.1× SSC-
0.5% SDS at 65° C for 30 min. The filter was exposed to radiographic
film at
80° C.
Plasmid Construction
The
281 to +110 region of the IL-2R
promoter was cloned by polymerase chain reaction (PCR) amplification of the 435 plasmid containing the
473 to +110 region of the IL-2R
promoter linked to the
chloramphenicol acetyltransferase (CAT) reporter gene. The
281 to
+110 fragment of the IL-2R
promoter was subcloned upstream of
the CAT reporter gene for functional testing of the NF-
B site in the
context of the IL-2R
promoter. To further define the role of the NF-
B site, oligonucleotides containing the wild-type or mutant NF-
B
site of the IL-2R
promoter were subcloned into the polylinker site
upstream of the herpes virus thymidine kinase (TK) promoter linked
to the CAT reporter gene. The oligonucleotide AGCTTTGGGGAATCTCCCTCTCCTTTTATGGGGATCC used to construct the
268W plasmid contained both an NF-
B site (underlined/bold) and
CArG site (italics). The 268S oligonucleotide AGCTTGGGGAATCTCCCTCTGGATCC contained only an NF-
B site, whereas the
268MI oligonucleotide AGCTTGCCTCTTTCTT TTCTGGATCC contained mutant NF-
B site (underlined). All plasmids were verified by
DNA sequencing and purified through CsCl2 centrifugation for transfections.
Transient Transfection and CAT Assays
THP-1 cells were transfected with DNA plasmids by the diethylaminoethyl (DEAE)-dextran method. 107 cells were washed with Tris-buffered saline solution (S-TBS; 25 mM Tris [pH 7.5], 137 mM NaCl, 5 mM KCl, 1 mM Na2HPO4, 1.4 mM CaCl2, 1 mM MgCl2), incubated with 10 µg plasmids in S-TBS containing 500 µg/ml DEAE-dextran for 1 h at 37° C, and then shocked with 10% dimethyl sulfoxide (DMSO) for 5 min. Transfected cells were cultured in RPMI 1640 containing 2.5% FCS for 48 h. Cells were then incubated with inducing agents for another 24 h and lysed by three cycles of freezing-thawing. Equal amounts of protein were incubated with 0.1 µCi of [14C]chloramphenicol-250 mM Tris (pH 7.5)-120 µM of acetyl coenzyme A at 37° C for 5 h. After extraction with ethyl acetate, samples were spotted on thin-layer chromatography plate and separated in 95% chloroform and 5% methanol. The plate was air-dried and exposed to X-ray film.
Electrophoretic Mobility Shift Assays (EMSAs)
THP-1 cells were stimulated with H37Ra or LPS for 4 h and nuclear
extracts were prepared from THP-1 cells as described previously (31).
Briefly, cells were lysed in buffer A (10 mM HEPES, pH 7.9, 1.5 mM
MgCl2, 10 mM KCl, 0.5 mM dithiothreitol [DTT]) containing 0.1%
Nonidet P-40 (NP-40) and 0.5 mM phenylmethylsulfonyl fluoride (PMSF) and centrifuged at 1,000 × g for 10 min at 4° C. The nuclei were extracted in buffer C (20 mM HEPES, pH 7.9, 25% glycerol, 0.42 M NaCl, 1.5 mM MgCl2, 0.2 mM EDTA, 0.5 mM DTT, 0.5 mM
PMSF) on ice for 30 min with shaking. The extracted nuclear proteins were frozen at
80° C until EMSA were performed. Double-stranded oligonucleotides were annealed and labeled with [
-32P]dCTP by Klenow fragment. Labeled probes (2 × 104 cpm) were incubated with 20 µg of nuclear extracts in binding buffer [10 mM Tris, pH 7.5, 10 mM
HEPES, pH 7.9, 50 mM KCl, 5 mM MgCl2, 1 mM EDTA, 1.25 mM
DTT, 2 µg of poly(dI-dC), 0.25 mM PMSF, and 10% glycerol] on ice
for 15 min in the presence or absence of antibodies or excess cold oligonucleotide. The DNA-protein complexes were electrophoresed on
a 5% polyacrylamide gel and analyzed by autoradiography.
| |
RESULTS |
|---|
|
|
|---|
Induction of IL-2R
Expression in TB
and in PBM by M. tuberculosis
Northern analysis of BAL cells lavaged from two normal control subjects and three patients with pulmonary TB revealed a
striking upregulation of IL-2-R
messenger RNA (mRNA)
level (Figure 1A). In two patients in whom we were able to lavage an uninvolved lobe to compare with a radiographically
involved lobe, the IL-2R
mRNA was increased only in the
involved lobes (Figure 2B). To control for RNA loading, the
filters were hybridized with
-actin, a housekeeping gene.
|
|
To examine the effects of stimulation by mycobacterial
components and heat-killed M. tuberculosis on the surface expression of IL-2R
on PBMs, unstimulated and stimulated
cells were incubated with anti-IL-2R
(CD25) antibody conjugated to FITC and analyzed by fluorescent-activated cell
sorter (FACS) analysis. Stimulation with heat-killed M. tuberculosis H37Ra resulted in a high level of surface expression of
IL-2R
, comparable to that induced with LPS (Figure 2). Costimulation of H37Ra or LPS with IFN-
resulted in a further
increase in IL-2R
expression. Treatment with IFN-
alone
did not result in the induction of surface expression of IL-2R
as compared with untreated cells. As controls for the nonspecific binding of Fc receptor, untreated and treated cells were
incubated with FITC-conjugated IgG and analyzed by FACScan. MFI ranged from 14.3 to 19.2, similar to that of untreated
and IFN-
-treated cells stained with FITC-CD25 antibody
(MFI of 17.2 and 19.7, respectively).
To examine if induction of IL-2R
expression occurred at
the mRNA level, PBM were stimulated with H37Ra in the
presence or absence of IFN-
and total RNA were analyzed by
Northern analysis. The expression of IL-2R
mRNA (3.5 kb
and 1.5 kb) in PBM was induced 12 h after stimulation with
H37Ra (Figure 3). Consistent with the enhancing effect of
IFN-
on H37Ra-induced surface expression of IL-2R
, induction of IL-2R
mRNA expression was further enhanced by costimulation with H37Ra and IFN-
. The same filter was
then probed with cDNA encoding the housekeeping gene
pHe7 to control for RNA loading.
|
Role of NF-
B in the Induction of
IL-2R
in THP-1 Cells
Because NF-
B has been shown to be important for regulation of expression of the IL-2R
gene in T cells, we were interested in investigating the role of NF-
B as an enhancer of the
IL-2R
promoter in monocytic cells. IL-2 has previously been
shown to act on PBM to enhance the binding activity of NF-
B
to the consensus sequence in the 5' regulatory region of the
IL-2R
promoter (27). To demonstrate the role of NF-
B in
the induction of IL-2R
by M. tuberculosis, the
281 to +110
region of the IL-2R
promoter containing the NF-
B site was
cloned upstream of the CAT reporter gene. This IL-2R
-CAT
construct was transfected into the human monocytic leukemia
cell line THP-1 and assayed for CAT activities. As shown in
Figure 4, stimulation with heat-killed M. tuberculosis H37Ra
(lane 2) strongly enhanced CAT activity as compared with unstimulated cells (lane 1). Stimulation with live M. tuberculosis H37Rv at a 1:1 ratio (bacteria:cell) also increased CAT activity (lane 3) which was more enhanced by stimulation with live
M. tuberculosis H37Rv at a 10:1 ratio (lane 4). Hence, both
heat-killed and live M. tuberculosis induced the IL-2R
promoter.
|
To further define the the role of the NF-
B site, oligonucleotides containing the wild-type or mutant NF-
B site were
cloned upstream of the heterologous herpes TK promoter
linked to the CAT reporter gene. These constructs were transfected into THP-1 cells and assayed for CAT activities. The
role of the CArG motif which binds serum response factor (SRF)
was also investigated because Kuang and coworkers (32) demonstrated that the SRF- and NF-
B-binding elements together
caused preferential expression of the IL-2R enhancer element
in T cells. In addition, mutations of the CArG motif also resulted in decreased activity of the IL-2R
promoter (33).
Transfection of the 268W construct (
268 to
243) which
contained both an NF-
B site and CArG motif conferred inducibility of CAT activities in response to stimulation with
H37Ra or LPS (Figure 5). To further define the role of NF-
B,
the 268S construct (
268 to
254) which contained only the
NF-
B site was transfected into THP-1 cells. CAT activities
were similarly enhanced upon stimulation with H37Ra or
LPS. Hence, the CArG motif does not function as an enhancer in monocytic cells in response to stimulation by H37Ra
or LPS. In contrast, inducibility of CAT activities by H37Ra
or LPS was strongly reduced when the 268MI construct which contained mutations in the NF-
B site was transfected into
THP-1 cells, demonstrating that the NF-
B site mediates induction in response to stimulation by M. tuberculosis or LPS.
|
EMSA Analysis of the NF-
B
Protein-DNA Complexes
To investigate the protein-DNA complexes that bind to the
NF-
B enhancer element, EMSA were performed. Nuclear
proteins isolated from unstimulated and stimulated THP-1
cells were incubated with end-labeled, double-stranded oligonucleotides containing the wild-type or mutant NF-
B site in
the presence or absence of cold competitors. After stimulation
with LPS or H37Ra, enhanced binding of nuclear protein to
the 268S probe containing the wild-type NF-
B site was observed (Figure 6). To examine the specificity of binding of
these nuclear proteins to the 268S oligonucleotide, competition experiments were performed by addition of excess cold
oligonucleotides containing the wild-type or mutant NF-
B
site. Binding of nuclear protein to the 268S probe was completely abolished by competition with excess cold 268S oligonucleotide but not with cold 268MI oligonucleotide containing
the mutant NF-
B site. The specificity of binding of these nuclear proteins was further demonstrated by the absence of
protein-DNA complexes when the 268MI probe was used in
EMSA.
|
To further evaluate the involvement of the NF-
B family
of proteins, EMSAs were performed in the presence of antibodies directed against the p50 and p65 subunits. As shown in
Figure 7, when EMSAs were performed in the absence of antibody, LPS or H37Ra induced the formation of two protein-
DNA complexes (I and II). Preincubation of nuclear extracts
with anti-p50 antibody reduced the formation of complex I
and supershifted complex II to a slower-migrating protein-
DNA complex. In contrast, addition of anti-p65 antibody reduced the formation of complex I without affecting the formation of complex II. These data suggest that complex II only
contained p50 protein, probably as p50 homodimers, whereas
complex I might be composed of both p50 and p65 proteins.
|
| |
DISCUSSION |
|---|
|
|
|---|
Soluble IL-2R
has been reported to be increased in sera of
patients with TB, especially those with advanced pulmonary
radiologic lesions, and concentrations decline after antituberculous therapy (5, 34). Significantly increased levels are found
in the pleural fluid compared with the sera in patients with tuberculous pleuritis (5). These investigators found no relationship between lack of response to PPD and soluble IL-2R
levels. CD4+ cells from the pleural space of patients with tuberculous pleurisy secrete greater quantities of IFN-
and IL-2
when stimulated with PPD of M. tuberculosis than the peripheral blood lymphocytes of the respective individuals (35). These
data suggest active migration of T lymphocytes from the peripheral blood, and are consistent with cellular activation. In
this context, BAL cells obtained from five TB patients had increased IL-2R
gene expression compared with two normal
control subjects.
Blood monocytes freshly isolated from patients with active
pulmonary TB have been demonstrated to express functional
IL-2R on their surface, perhaps due to exposure of monocytes
to mycobacterial products. Toossi and coworkers (4) proposed
that constitutive expression of functional IL-2R on monocytes
from patients with TB and the increased release of IL-2R after
exposure to mycobacterial products may contribute to antigen-specific suppression by adherent cells and depression of
delayed-type hypersensitivity, as assessed by tuberculin skin
tests. Interactions of IL-2 with monocyte IL-2R may also limit
the availability of IL-2 for T cells, leading to depression of
T-cell immune responses. However, interleukin-10 and transforming growth factor-
may also contribute to depressed cellular immune responses in TB (36, 37). When monocytes are cultured with IL-2, both superoxide generation and cytotoxicity against the extracellular protozoa Giardia lamblia are enhanced (15). In addition, intracellular killing of M. avium complex by monocytes is potentiated when IL-2 is added along
with TNF, suggesting that interactions of IL-2 with IL-2R may
contribute to microbicidal host defenses (10).
Because expression of IL-2R
is important for the formation of high-affinity IL-2 binding sites, induction of expression
of IL-2R
may be critical for monocytes to respond to the low
concentration of IL-2 that may be found in vivo in the microenvironments. Hence, studying the molecular mechanism
of IL-2R
gene regulation by in vitro stimulation with M. tuberculosis is important for understanding the immunomodulatory role and effector function of monocytes during tuberculosis. We have previously shown that both NF-
B and NF-IL6 sites are involved in mediating response of the IL-6 promoter to stimulation by cell wall components of mycobacteria (38). We have shown here that expression of both IL-2R
mRNA
and protein can be induced by M. tuberculosis. We have also
shown that, similar to that in T cells (39), NF-
B plays an important role in the positive regulation of IL-2R
gene expression in monocytes stimulated by M. tuberculosis. Mutations of
the NF-
B site abolished both response to stimulation by M. tuberculosis and specific binding of nuclear proteins to the NF-
B site. Using antibodies directed against p50 and p65 proteins, binding of the p50 homodimer and p50/p65 heterodimer
to the NF-
B site was also demonstrated. It is likely that the
constitutive expression of IL-2R on monocytes from patients
with tuberculosis may be due to activation of NF-
B by mycobacterial products in vivo.
An essential role for NF-
B in preventing TNF-
-induced
apoptosis has recently been described (40). Intracellular
infection by Leishmania donovani has been shown to inhibit
macrophage apoptosis (43). Because M. tuberculosis can activate NF-
B and induction of apoptosis of infected monocytes
resulted in killing of intracellular bacillus Calmette-Guérin
and reduced viability of M. avium-M. intracellulare (44, 45),
activation of NF-
B may be a protective mechanism for the
survival of M. tuberculosis. Further studies to test this hypothesis in vivo would be of interest.
We recently demonstrated that a subgroup of pulmonary
TB patients have an enrichment of CD4+ cells with a T helper
cell, type 1 (Th1) response in the involved segments (46, 47).
BAL cells from this subgroup released IFN-
, and not IL-4.
At presentation, these patients had less clinically and radiographically advanced TB (smear-negative, noncavitary disease). Treatment of five patients with multidrug-resistant TB
by aerosolized IFN-
converted sputum acid-fast bacillus
smears from positive to negative (48). Because IL-2 release is
also part of the Th1 response, IL-2 has been administered subcutaneously to multidrug-resistant TB patients or acquired
immunodeficiency syndrome (AIDS) patients to augment the
Th1 response (49, 50). Clinical responses included reduction
of bacillary load accompanied by radiographic improvement
in multidrug-resistant TB patients and prevention of opportunistic infections in AIDS patients. This was a result of increased IL-2R on T cells (increased CD25+ cells), increased
natural killer cells (CD56+ cells), and enhanced expression of
the IFN-
gene (49, 50). Exogenous administration of Th1 cytokines likely increases IL-2R augmenting the Th1 response,
leading toward a more propitious clinical response to mycobacterial infection (51).
| |
Footnotes |
|---|
Correspondence and requests for reprints should be addressed to Kam-Meng Tchou-Wong, Ph.D., New York University Medical Center, Division of Pulmonary and Critical Care Medicine, 550 First Avenue, MSB 147, New York, NY 10016.
(Received in original form October 31, 1997 and in revised form October 8, 1998).
O. Tanabe is currently at the Jikei University School of Medicine, Department of Internal Medicine, Tokyo, JapanAcknowledgments: The authors thank Natalie Little for editorial assistance.
Supported by Grants MO1 00096, HL59832, HL62055, and CDC CCU210075 to W.R., and ES09161 and an American Lung Association Research grant to K-M.T-W.
| |
References |
|---|
|
|
|---|
1. Orme, I. M., A. D. Roberts, J. P. Griffin, and J. S. Abrams. 1993. Cytokine secretion by CD4 T lymphocytes acquired in response to Mycobacterium tuberculosis infection. J. Immunol. 151: 518-525 [Abstract].
2.
Cooper, A. M.,
D. K. Dalton,
T. A. Stewart,
J. P. Griffin,
D. G. Russell, and
I. M. Orme.
1993.
Disseminated tuberculosis in interferon
gene
disrupted mice.
J. Exp. Med.
173:
2243-2247
.
3. Schauf, V., W. N. Rom, K. A. Smith, W. P. Sampaio, P. A. Meyn, J. M. Tramontana, Z. A. Cohn, and G. Kaplan. 1993. Cytokine gene activation and modified responsiveness to interleukin-2 in the blood of tuberculosis patients. J. Infect. Dis. 168: 1056-1059 [Medline].
4. Toossi, Z., J. R. Sedor, J. P. Lapurga, R. J. Ondash, and J. J. Ellner. 1990. Expression of functional interleukin 2 receptors by peripheral blood monocytes from patients with active pulmonary tuberculosis. J. Clin. Invest. 85: 1777-1784 .
5.
Takahashi, S.,
Y. Setoguchi,
T. Nukiwa, and
S. Kira.
1991.
Soluble interleukin-2 receptor in sera of patients with pulmonary tuberculosis.
Chest
99:
310-314
6. Holden, M., M. R. Dublin, and P. H. Diamond. 1971. Frequency of negative intermediate-strength tuberculin sensitivity in patients with active tuberculosis. N. Engl. J. Med. 285: 1506-1509 .
7.
Nash, D. R., and
J. E. Douglas.
1980.
Anergy in active pulmonary tuberculosis.
Chest
77:
32-37
8.
Ellner, J. J..
1978.
Suppressor adherent cells in human tuberculosis.
J. Immunol.
121:
2573-2579
9.
Toossi, Z.,
M. E. Kleinheinz, and
J. J. Ellner.
1986.
Defective interleukin
2 production and responsiveness in human pulmonary tuberculosis.
J.
Exp. Med.
163:
1162-1172
10.
Bermudez, L. E. M., and
L. S. Young.
1988.
Tumor necrosis factor, alone
or in combination with IL-2, but not IFN-
, is associated with macrophage killing of Mycobacterium avium complex.
J. Immunol.
140:
3006-3013
[Abstract].
11.
Herrmann, J.,
S. A. Cannistra,
H. Levine, and
J. D. Griffin.
1985.
Expression of interleukin 2 receptors and binding of interleukin 2 by
gamma interferon-induced human leukemic and normal monocytic
cells.
J. Exp. Med.
162:
1111-1116
12.
Holter, W.,
C. K. Goldman,
L. Casabo,
D. L. Nelson,
W. C. Greene, and
T. A. Waldmann.
1987.
Expression of functional IL 2 receptors by lipopolysaccharide and interferon-
stimulated human monocytes.
J.
Immunol.
138:
2917-2922
[Abstract].
13.
Holter, W.,
R. Grunow,
H. Stockinger, and
W. Knapp.
1986.
Recombinant interferon-
induces interleukin 2 receptors on human peripheral
blood monocytes.
J. Immunol.
136:
2171-2175
[Abstract].
14. Rambaldi, A., D. C. Young, F. Herrmann, S. A. Cannistra, and J. D. Griffin. 1987. Interferon-gamma induces expression induction of the interleukin 2 receptor gene in human monocytes. Eur. J. Immunol. 17: 153-156 [Medline].
15. Wahl, S. M., N. McCartney-Francis, D. A. Hunt, P. D. Smith, L. M. Wahl, and I. M. Katona. 1987. Monocyte interleukin 2 receptor gene expression and interleukin 2 augmentation of microbicidal activity. J. Immunol. 139: 1342-1347 [Abstract].
16. Taniguchi, T., and Y. Minami. 1993. The IL-2/IL-2 receptor system: a current overview. Cell 73: 5-8 [Medline].
17.
Bosco, M. C.,
I. Espinoza-Delgado,
M. Schwabe,
S. M. Russell,
W. J. Leonard,
D. L. Longo, and
L. Varesio.
1994.
The gamma subunit of the
IL-2R is expressed in human monocytes and modulated by IL-2, IFN-gamma, and TGF beta.
Blood
83:
3462-3467
18.
Espinoza-Delgado, I.,
D. L. Longo,
G. L. Gusella, and
L. Varesio.
1992.
Regulation of IL-2 receptor subunit genes in human monocytes: differential effects of IL-2 and IFN-
.
J. Immunol.
149:
2961-2968
[Abstract].
19.
Espinoza-Delgado, I.,
J. R. Ortaldo,
R. Winkler-Pickett,
K. Sugamura,
L. Varesio, and
D. L. Longo.
1990.
Expression and role of p75 interleukin 2 receptor on human monocytes.
J. Exp. Med.
171:
1821-1826
20. Malkovsky, M., B. Loveland, M. North, L. Asherson, L. Gao, P. Ward, and W. Fiers. 1987. Recombinant interleukin-2 directly augments the cytotoxicity of human monoctyes. Nature 325: 262-265 [Medline].
21. Kniep, E. M., and M.-L. Lohmann-Matthes. 1992. The monocyte interleukin-2 receptor light chain: production of cell-associated and soluble interleukin-2 receptor by monocytes. Immunol. 75: 299-304 [Medline].
22. Espinoza-Delgado, I., M. C. Bosco, T. Musso, G. L. Gusella, D. L. Longo, and L. Varesio. 1995. Interleukin-2 and human monocyte activation. J. Leuk. Biol. 57: 13-19 [Abstract].
23.
Smith, K. A..
1988.
Interleukin-2: inception, impact, and implications.
Science
240:
1169-1176
24.
Lenardo, M. J., and
D. Baltimore.
1989.
NF-
B: a pleiotropic mediator
of inducible and tissue-specific gene control.
Cell
58:
227-229
[Medline].
25.
Baeuerle, P. A., and
T. Henkel.
1994.
Function and activation of NF-
B
in the immune system.
Annu. Rev. Immunol.
12:
141-179
[Medline].
26. Böhnlein, E., J. W. Lowenthal, M. Siekevitz, D. W. Ballard, B. R. Franza, and W. C. Greene. 1988. The same inducible nuclear proteins regulates mitogen activation of both the interleukin-2 receptor-alpha gene and type 1 HIV. Cell 53: 827-836 [Medline].
27.
Cross, S. L.,
N. F. Halden,
M. J. Lenardo, and
W. J. Leonard.
1989.
Functionally distinct NF-
B binding sites in the immunoglobulin
and
IL-2 receptor
chain genes.
Science
244:
466-469
28.
Lin, B. B.,
S. L. Cross,
N. F. Halden,
D. G. Roman,
M. B. Toledano, and
W. J. Leonard.
1990.
Delineation of an enhancer-like positive regulatory element in the interleukin-2 receptor
-chain gene.
Mol. Cell.
Biol.
10:
850-853
29.
Brach, M. A.,
H.-J. Gruss,
D. Riedel,
R. Mertelsmann, and
F. Herrmann.
1992.
Activation of NF-
B by interleukin 2 in human blood
monocytes.
Cell Growth Different.
3:
421-427
.
[Abstract]
30. Zhang, Y., M. Broser, H. Cohen, M. Bodkin, K. Law, J. Reibman, and W. N. Rom. 1995. Enhanced interleukin-8 release and gene expression in macrophages after exposure to Mycobacterium tuberculosis and its components. J. Clin. Invest. 95: 586-592 .
31.
Zhang, Y., and
W. N. Rom.
1993.
Regulation of the interleukin-1
(IL-1
) gene by mycobacterial components and lipopolysaccharide is mediated by two nuclear factor-IL6 motifs.
Mol. Cell. Biol.
13:
3831-3837
32.
Kuang, A. A.,
K. D. Novak,
S. M. Kang,
K. Bruhn, and
M. J. Lenardo.
1993.
Interaction between NF-
B and serum response factor-binding
elements activates an interleukin-2 receptor alpha-chain enhancer
specifically in T lymphocytes.
Mol. Cell. Biol.
13:
2536-2545
33.
Toledano, M. B.,
D. G. Roman,
N. F. Hulden,
B. B. Lin, and
W. J. Leonard.
1990.
The same target sequences are differentially important
for activation of the interleukin 2 receptor
-chain gene in two distinct
T-cell lines.
Proc. Natl. Acad. Sci. U.S.A.
87:
1830-1834
34. Choi, S. J., Y. S. Moon, B. C. Lee, and D. S. Kim. 1990. Serum levels of soluble interleukin-2 receptor in pulmonary tuberculosis. Korean J. Int. Med. 5: 44-50 .
35.
Riberd, E.,
I. Ocana,
J. M. Martinez-Vazquez,
M. Rosell,
T. Espanol, and
A. Ruibal.
1988.
High level of interferon gamma in tuberculosis
pleural effusion.
Chest
93:
308-311
36.
Toosi, Z.,
P. Gozate,
H. Shiratsuchi,
T. Young, and
J. J. Ellner.
1995.
Enhanced production of TGF-
by blood monocytes from patients with
active tuberculosis and presence of TGF-
in tuberculous granulomatous lung lesions.
J. Immunol.
154:
465-473
[Abstract].
37.
Hirsch, C. S.,
R. Hussain,
Z. Toosi,
G. Dawood,
F. Shahid, and
J. J. Ellner.
1996.
Cross-modulation by transforming growth factor
in human tuberculosis: suppression of antigen driven blastogenesis and interferon-
production.
Proc. Natl. Acad. Sci. U.S.A.
93:
3193-3198
38.
Zhang, Y.,
M. Broser, and
W. N. Rom.
1994.
Activation of the interleukin 6 gene by Mycobacterium tuberculosis or lipopolysaccharide is mediated by nuclear factors NF-IL6 and NF-
B.
Proc. Natl. Acad. Sci.
U.S.A.
91:
2225-2229
39.
Pimentel-Muiños, J. X.,
J. Mazana, and
M. Fresno.
1994.
Regulation of
interleukin-2 receptor
chain expression and nuclear factor
B activation by protein kinase C in T lymphocytes: autocrine role of tumor
necrosis factor
.
J. Biol. Chem.
269:
24424-24429
40.
Beg, A. A., and
D. Baltimore.
1996.
An essential role for NF-
B in preventing TNF-
-induced cell death.
Science
274:
782-784
41.
Van Antwerp, D. J.,
S. J. Martin,
T. Kafri,
D. R. Green, and
I. M. Verma.
1996.
Suppression of TNF
-induced apoptosis by NF-
B.
Science
274:
787-789
42.
Wang, C.-Y.,
M. W. Mayo, and
A. S. Baldwin Jr..
1996.
TNF- and cancer
therapy-induced apoptosis: potentiation by inhibition of NF-
B.
Science
274:
784-787
43. Moore, K. J., and G. Matlashewski. 1994. Intracellular infection by Leishmania donovani inhibits macrophage apoptosis. J. Immunol. 152: 2930-2937 [Abstract].
44. Laochumroonvorapong, P., S. Paul, K. B. Elkon, and G. Kaplan. 1996. H2O2 induces monocyte apoptosis and reduces viability of Mycobacterium avium-M. intracellulare within cultured human monocytes. Infect. Immun. 64: 452-459 [Abstract].
45.
Molloy, A.,
P. Laochumroonvorapong, and
G. Kaplan.
1994.
Apoptosis,
but not necrosis, of infected monocytes is coupled with killing of intracellular bacillus Calmette-Guérin.
J. Exp. Med.
180:
1499-1509
46. Law, K. F., J. Jagirdar, M. Weiden, M. Bodkin, and W. N. Rom. 1996. Tuberculosis in HIV positive patients: cellular response and immune activation in the lung. Am. J. Respir. Crit. Care Med. 153: 1377-1384 [Abstract].
47.
Condos, R.,
W. N. Rom,
Y. M. Liu, and
N. W. Schluger.
1998.
Local immune responses correlate with presentation and outcome in tuberculosis.
Am. J. Respir. Crit. Care Med.
157:
729-735
48.
Condos, R.,
W. N. Rom, and
N. W. Schluger.
1997.
Treatment of multidrug-resistant pulmonary tuberculosis with interferon-
via aerosol.
Lancet
349:
1513-1515
[Medline].
49. Johnson, B. J., L.-G. Bekker, R. Rickman, S. Brown, M. Lesser, S. Ress, P. Willcox, L. Steyn, and G. Kaplan. 1997. rhu IL-2 adjunctive therapy in multidrug resistant tuberculosis: a comparison of two treatment regimens and placebo. Tubercle Lung Dis. 78: 195-203 [Medline].
50. Khatri, V. P., T. A. Fehniger, R. A. Baiocchi, F. Yu, M. H. Shah, D. S. Schiller, M. Gould, R. T. Gazzinelli, Z. P. Bernstein, and M. A. Caligiuri. 1998. Ultra low dose interleukin-2 therapy promotes a type 1 cytokine profile in vivo in patients with AIDS, and AIDS-associated malignancies. J. Clin. Invest. 101: 1373-1378 [Medline].
51. Schluger, N. W., and W. N. Rom. 1998. State of the art: the human host response to M. tuberculosis. Am. J. Respir. Crit. Care Med. 157: 679-691 .
This article has been cited by other articles:
![]() |
V. Guyot-Revol, J. A. Innes, S. Hackforth, T. Hinks, and A. Lalvani Regulatory T Cells Are Expanded in Blood and Disease Sites in Patients with Tuberculosis Am. J. Respir. Crit. Care Med., April 1, 2006; 173(7): 803 - 810. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Renaud, L.-M. Postovit, S. K. Macdonald-Goodfellow, G. T. McDonald, J. D. Caldwell, and C. H. Graham Activated Macrophages Inhibit Human Cytotrophoblast Invasiveness In Vitro Biol Reprod, August 1, 2005; 73(2): 237 - 243. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-H. Song, J.-S. Lee, H.-J. Kim, J.-K. Park, T.-H. Paik, and E.-K. Jo Interleukin-8 Is Differentially Expressed by Human-Derived Monocytic Cell Line U937 Infected with Mycobacterium tuberculosis H37Rv and Mycobacterium marinum Infect. Immun., October 1, 2003; 71(10): 5480 - 5487. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Mendez-Samperio, H. Ayala, and A. Vazquez NF-{kappa}B Is Involved in Regulation of CD40 Ligand Expression on Mycobacterium bovis Bacillus Calmette-Guerin-Activated Human T Cells Clin. Vaccine Immunol., May 1, 2003; 10(3): 376 - 382. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Prabhakar, Y. Qiao, Y. Hoshino, M. Weiden, A. Canova, E. Giacomini, E. Coccia, and R. Pine Inhibition of Response to Alpha Interferon by Mycobacterium tuberculosis Infect. Immun., May 1, 2003; 71(5): 2487 - 2497. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Gutierrez-Pabello, D. N. McMurray, and L. G. Adams Upregulation of Thymosin {beta}-10 by Mycobacterium bovis Infection of Bovine Macrophages Is Associated with Apoptosis Infect. Immun., April 1, 2002; 70(4): 2121 - 2127. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. EDWARDS, M. H. CYNAMON, R. K. R. VOLADRI, C. C. HAGER, M. S. DESTEFANO, K. T. THAM, D. L. LAKEY, M. R. BOCHAN, and D. S. KERNODLE Iron-cofactored Superoxide Dismutase Inhibits Host Responses to Mycobacterium tuberculosis Am. J. Respir. Crit. Care Med., December 15, 2001; 164(12): 2213 - 2219. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Warwick-Davies, A. J. Watson, G. E. Griffin, S. Krishna, and R. J. Shattock Enhancement of Mycobacterium tuberculosis-Induced Tumor Necrosis Factor Alpha Production from Primary Human Monocytes by an Activated T-Cell Membrane-Mediated Mechanism Infect. Immun., November 1, 2001; 69(11): 6580 - 6587. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yamada, S. Mizuno, M. Reza-Gholizadeh, and I. Sugawara Relative Importance of NF-kappa B p50 in Mycobacterial Infection Infect. Immun., November 1, 2001; 69(11): 7100 - 7105. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Raju, C. F. Tung, D. Cheng, N. Yousefzadeh, R. Condos, W. N. Rom, and D. B. Tse In Situ Activation of Helper T Cells in the Lung Infect. Immun., August 1, 2001; 69(8): 4790 - 4798. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. Thorac. Soc. | Am. J. Respir. Cell Mol. Biol. |